Palantir Just Hit $1 Billion in Quarterly Revenue. Here's How It Compares With the Magnificent Seven.
It took Palantir 22 years to reach $1 billion in quarterly revenue.
The rest of the Magnificent Seven hit that milestone in less time.
Palantir's valuation remains sky high.
These 10 stocks could mint the next wave of millionaires ›
Palantir (NASDAQ: PLTR) has given shareholders plenty to celebrate once again.
The high-flying data analytics company blew away expectations for the second quarter. Its revenue growth accelerated, this time coming in at 48%, topping the $1 billion mark for the first time. That was well ahead of the analyst consensus at $939.5 million.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
U.S. revenue growth was exceptionally strong at 68%, reaching $733 million as both the federal government and private sector embrace Palantir's artificial intelligence (AI) platform. The company also closed $2.27 billion in total contract value, up 140%, showing that there's a long runway of growth ahead.
Operating income surged as well, up 156% year over year to $269 million, on a generally accepted accounting principles (GAAP) basis, and adjusted earnings per share (EPS) rose to $0.16, ahead of estimates at $0.14.
The already pricey stock rose 7.8% on Aug. 5, showing the company was able to top a high bar.
How Palantir compares to the competition
Palantir has been on an incredible hot streak as the artificial intelligence (AI) stock was the top performer in the S&P 500 last year. It's the best performer year to date too, up 133% as of this writing.
Its market cap has risen to nearly $420 billion, making it one of the 20 most valuable companies in the U.S.
With $1.004 billion of revenue last quarter, Palantir needed about 22 years to reach the billion-dollar milestone. Here's how its path compares with some of the market's other big winners -- the Magnificent Seven.
Company Time to Reach $1 billion
in Quarterly Revenue Market Cap at
Time of Milestone
Palantir 22 years $323.3 billion
Tesla 12 years $19.0 billion
Meta Platforms 8 years N/A
Alphabet 6 years $52.8 billion
Amazon 7 years $4.0 billion
Microsoft 18 years $24.8 billion
Apple 11 years $4.1 billion
Nvidia 14 years $19.7 billion
Source: Ycharts.
Looking at the chart above, you'll notice two things about Palantir. First, it took the company longer from its founding to reach $1 billion in revenue than any other company on the list.
That's not necessarily a problem. Some of these businesses scaled faster than others for a unique reason. Alphabet, then Google, struck gold with its search engine, as did Meta with Facebook. Amazon, meanwhile, was able to scale its e-commerce business quickly.
Palantir, on the other hand, has evolved significantly since its founding in 2003 when the company got its start helping intelligence agencies connect the dots hidden in its data. More recently, the company has rapidly evolved thanks to the launch of its Artificial Intelligence Platform (AIP) in 2023, which has substantially accelerated its revenue growth.
What's more concerning is the market cap attached to Palantir as the stock was much more expensive than any of the Magnificent Seven were when they crossed the $1 billion milestone. In fact, with a price-to-sales ratio over 130, Palantir is much more expensive than any other stock in the S&P 500 (based on that metric).
What it means for Palantir
After the latest report, there's little doubt Palantir's business continues to fire on all cylinders. The Trump administration has also embraced its platform to help revamp the government, boost ICE deportations, and improve efficiency, and U.S. businesses are following suit.
The company also raised its full-year guidance again, calling for revenue of $4.146 billion and $1.916 billion in adjusted operating income (both figures at the midpoint of their respective ranges).
Given the surge in bookings, Palantir appears to be in good shape for at least the next few quarters. However, its valuation will eventually hamper further gains for the stock.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,047%* — a market-crushing outperformance compared to 181% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
*Stock Advisor returns as of August 4, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Occidental Petroleum's Resilient Q2 2025 Performance
Occidental Petroleum Corp. ((OXY)) has held its Q2 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Occidental Petroleum Corp.'s recent earnings call painted a picture of resilience and strategic advancement, despite facing challenges from lower oil prices and oversupply issues in its OxyChem segment. The company emphasized its strong operational performance, significant debt reduction, and progress in low carbon ventures, showcasing its preparedness for future growth. Strong Cash Flow and Debt Reduction Occidental reported a robust $2.6 billion in operating cash flow for Q2 2025, even amid lower oil prices. The company achieved a remarkable debt reduction, repaying $7.5 billion within a year, which represents nearly a 70% reduction of the debt incurred for the CrownRock acquisition. This financial maneuvering underscores Occidental's commitment to strengthening its balance sheet. Operational Efficiency and Cost Savings The company highlighted significant operational efficiencies, achieving $150 million in expected operating cost savings in its U.S. onshore operations. This resulted in a reduction of per barrel costs to $8.55. International operations also contributed to cost savings, with an estimated $50 million reduction in operating expenses. Permian Basin and Well Performance Occidental reported improved drilling times in the Delaware Basin, achieving a 20% reduction, which lowered well costs below the 2025 target. Additionally, year-to-date Permian unconventional well costs saw a 13% decrease compared to 2024, reflecting the company's focus on cost-effective production. Midstream and Marketing Segment Success The midstream and marketing segment exceeded expectations, generating positive earnings due to improved crude marketing margins and higher sulfur pricing. This performance highlights the segment's ability to adapt and thrive in a challenging market environment. Advancements in Low Carbon Ventures Occidental made significant strides in its low carbon ventures, with the STRATOS project reaching a milestone as Trains 1 & 2 moved to operations. The company also signed new commercial agreements for carbon dioxide removal cells, reinforcing its commitment to environmental sustainability. Lower Oil Prices Impact The company faced a challenging environment with much lower oil prices in the first half of 2025. The average WTI price was $11 per barrel lower compared to the first half of 2024, impacting revenue streams. OxyChem Segment Challenges OxyChem faced difficulties with pre-tax income falling below guidance due to weaker-than-expected pricing for caustic and PVC. An oversupply in the market further pressured margins, presenting challenges for the segment. Gulf of America Production Constraints Production in the Gulf of America was constrained primarily due to third-party issues. As a result, Occidental reduced its offshore production guidance for the second half of the year, citing ongoing effects from these curtailments. Forward-Looking Guidance Looking ahead, Occidental provided guidance that emphasizes continued operational efficiency and financial discipline. The company reported operating cash flow of $2.6 billion for the second quarter and total production of 1.4 million BOE per day, surpassing production guidance. Debt reduction remains a priority, with $7.5 billion repaid following the CrownRock acquisition. The company also lowered capital guidance by $100 million, benefiting from improved drilling efficiencies in the Delaware Basin. Advancements in the STRATOS project and new carbon management agreements further highlight Occidental's forward-looking strategy. In conclusion, Occidental Petroleum Corp.'s earnings call reflected a company poised for growth, despite external pressures. The focus on debt reduction, operational efficiencies, and low carbon initiatives positions Occidental well for future success. Investors and market watchers will be keen to see how these strategies unfold in the coming quarters.
Globe and Mail
an hour ago
- Globe and Mail
CFLT Investors Have Opportunity to Join Confluent, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Confluent, Inc. ('Confluent' or 'the Company') (NASDAQ: CFLT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Confluent announced its Q2 2025 financial results on July 30, 2025. The Company's CFO announced during its earnings call that "consumption growth was impacted by continued optimization with month-over-month trends trailing the same period in prior years" and that "an AI-native customer has been making a broad-based move towards self-management of internal data platforms, reducing their Confluent Cloud usage as a result." Based on this news, shares of Confluent fell by more than 32.8% on the next day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Globe and Mail
2 hours ago
- Globe and Mail
ALT5 Sigma Corporation Announces Closing of $1.5 Billion Registered Direct Offering and Concurrent Private Placement to Initiate World Liberty Financial $WLFI Treasury Strategy
ALT5 Sigma Corporation (NASDAQ: ALTS)(FRA: 5AR1) (the 'Company' or 'ALT5') today announced the closing of a $1.5 billion registered direct offering (the 'Registered Direct Offering') and concurrent private placement (the 'Private Placement Offering' and, together with the Registered Direct Offering, the 'Offerings') led by World Liberty Financial, Inc. ('World Liberty Financial'). The gross proceeds of the Offerings were approximately $1.5 billion, before deducting placement agent fees and other offering expenses. The Offerings were priced at-the-market pursuant to Nasdaq rules. Zach Witkoff, co-founder and CEO of World Liberty Financial became Chairman of the board of directors of the Company, Eric Trump became a director on the Company's board of directors, Zak Folkman, co-founder and COO of World Liberty Financial, became a board observer to the Company, and Matt Morgan became Chief Investment Officer of the Company. World Liberty Financial acted as the lead investor in the concurrent private placement offering, and the Offerings included participation by a select number of the world's largest institutional investors and prominent crypto venture capital firms. Kraken will serve as the Asset Manager. A.G.P./Alliance Global Partners acted as the sole placement agent in connection with the Offerings. The securities offered in the Registered Direct Offering (but excluding the securities offered in the Private Placement Offering) were offered and sold by ALT5 pursuant to a 'shelf' registration statement on Form S-3 (Registration No. 333-289176), including a base prospectus, previously filed with the Securities and Exchange Commission (the 'SEC') on August 1, 2025 and declared effective by the SEC on August 8, 2025. The offering of the securities to be issued in the Registered Direct Offering were being made only by means of a prospectus supplement that forms a part of the registration statement. A final prospectus supplement and an accompanying base prospectus relating to the Registered Direct Offering was filed with the SEC on August 11, 2025, and is available on the SEC's website located at The offer and sale of the securities in the Private Placement Offering described above were being made in transactions not involving a public offering and have not been registered pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the 'Securities Act'), and/or Rule 506(b) of Regulation D promulgated thereunder and have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities in the Private Placement Offering may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. Advisors Sullivan & Worcester LLP acted as legal advisor to A.G.P./Alliance Global Partners. HSF Kramer LLP acted as special counsel to A.G.P./Alliance Global Partners. Lucosky Brookman LLP and Clark Hill PLC acted as legal advisors to ALT5 Sigma Corporation. About ALT5 Sigma ALT5 Sigma Corporation (NASDAQ: ALTS)(FRA:5AR1) is a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing settlement, payment and safe keeping of digital assets. Since June of 2025, the Company has been a member of the Russell Microcap Growth ®, Russell 3000E ®, and Russell 3000E Growth ® Indexes, as part of the 2025 Russell indexes reconstitution. The Company had previously been included in the Russell Microcap ® Index since June of 2024. Founded in 2018, ALT5 Sigma, Inc. (a wholly owned subsidiary of ALT5 Sigma Corporation), provides next-generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma, Inc., through its subsidiaries, offers two main platforms to its customers: 'ALT5 Pay' and 'ALT5 Prime.' ALT5 Sigma has processed over $5 billion USD in cryptocurrency transactions since inception. ALT5 Pay is an award-winning cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency(s) automatically or to receive their payment in digital assets. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named 'ALT5 Pro' that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers. The Company is working on the potential separation of its biotech business that will move forward under 'Alyea Therapeutics Corporation.' Through its biotech activities, the Company is focused on bringing to market drugs with non-addictive pain-relieving properties to treat conditions that cause chronic or severe pain. The Company's patented product, a novel formulation of low-dose naltrexone (JAN123), is being initially developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs. The FDA has granted JAN123 Orphan Drug Designation for treatment of CRPS. The Company is expected to adopt a $WLFI Treasury Strategy. About World Liberty Financial World Liberty Financial (WLFI) is a pioneering decentralized finance (DeFi) protocol and governance platform dedicated to empowering individuals through transparent, accessible, and secure financial solutions. Inspired by the vision of President Donald J. Trump, WLFI seeks to democratize access to DeFi by creating user-friendly tools that bring the benefits of decentralized finance to a broader audience. WLFI plans to be at the forefront of DeFi, offering an intuitive, robust platform that empowers users to participate actively in the financial future. Forward-Looking Statements This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the expected use of proceeds from the Offerings, the Company's expectation to initiate its $WLFI Treasury Strategy, the profitability and prospective growth of ALT5's platforms and business that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion, and statements regarding the Company's potential separation plans of its biotech business. This press release also contains general statements relating to risks that the Company's potential separation plans of its biotech business and the potential for JAN123 to treat CRPS, and other statements, including words such as 'continue', 'expect', 'intend', 'will', 'hope', 'should', 'would', 'may', 'potential', and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies. This press release also contains statements that are forward-looking in respect of the expected future partial or full disposition of the Company's interests in Alyea without specificity of the scope or methods thereof. Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the 'SEC'). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled 'Risk Factors' in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
